Skip to main content
. 2023 Aug 2;16:89. doi: 10.1186/s13045-023-01477-7

Table 2.

The role of METTL1 in various cancers

Role Cancer MTTL1 Targets Downstream Prognosis* Mechanism Cellular function References
Oncogene HCC HDGF Poor m7G tRNAs Proliferation [74]
TGF-β2 PMN-MDSCs Poor m7G tRNAs Immunosuppressive microenvironment [75]
EGFR Poor m7G tRNAs lenvatinib resistance [250]
DNA-PKcs or DNA ligase IV NHEJ-mediated DNA DSB repair Poor m7G tRNAs Radiotherapy resistance [165]
SLUG/SNAIL DNA repair Poor m7G tRNAs Metastasis [166]
NPC WNT/β-catenin Poor m7G tRNAs EMT, chemoresistance [80]
Lung cancer Proliferation-associated mRNA Poor m7G tRNAs Growth, migration, and invasion [168]
ICC EGFR, cell cycle-associated mRNA Poor m7G tRNAs Proliferation [167]
CXCL8 PMN-MDSCs Poor m7G tRNAs Immunosuppressive [232]
Bladder cancer EGFR/EFEMP1 Poor m7G tRNAs Proliferation, migration, and invasion [76]
ESCC RPOTOR/ULK1 Poor m7G tRNAs Proliferation, autophagy [78]
MTORC1 ULK1 Poor m7G tRNAs Autophagy [79]
GC Cell cycle-associated mRNA AKT/STAT3 Poor m7G tRNAs Proliferation [81]

*Represents the correlation of a higher expression level of METTL1 with a good or poor prognosis